AmCad BioMed Corporation (TPEX:4188)
Taiwan · Delayed Price · Currency is TWD 11.15
-0.10 (-0.89%)
May 29, 2026, 1:30 PM CST
AmCad BioMed Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -53.66 | -55.72 | -50.58 | -45.31 | -53.49 | -25.54 |
Depreciation & Amortization | 15.58 | 15.47 | 18 | 17.16 | 17.27 | 17.9 |
Other Amortization | 0.33 | 0.33 | 0.28 | 0.3 | 0.35 | 0.38 |
Loss (Gain) From Sale of Assets | 0.17 | 0.22 | 0.19 | 0.17 | 0.01 | 0.08 |
Loss (Gain) From Sale of Investments | -0.42 | -0.46 | -0.03 | -0 | -0.02 | -0 |
Stock-Based Compensation | 0.64 | 0.64 | 2.9 | 0.68 | 0.82 | 0.54 |
Provision & Write-off of Bad Debts | - | - | - | - | -0.05 | -0.1 |
Other Operating Activities | -14.71 | -15.71 | -2.31 | 2.16 | -0.86 | -1.35 |
Change in Accounts Receivable | 8.1 | 11.31 | -9.31 | -6.84 | 1.33 | -2.93 |
Change in Inventory | -0.7 | 0.48 | -11.61 | -5.41 | -2.6 | 0.02 |
Change in Accounts Payable | -0.8 | -1.42 | 0.9 | 0.96 | -0.21 | -0.04 |
Change in Unearned Revenue | 0.36 | -0.06 | -1.54 | -0.61 | -2.78 | -31.61 |
Change in Other Net Operating Assets | -1.8 | -2.15 | 1.25 | -4.86 | 6.03 | 3.68 |
Operating Cash Flow | -46.91 | -47.06 | -51.85 | -41.6 | -34.19 | -38.97 |
Capital Expenditures | -0.2 | -0.37 | -2.72 | -0.29 | -0.61 | -2.34 |
Sale (Purchase) of Intangibles | -0.33 | -0.33 | -0.33 | - | - | - |
Investment in Securities | 42.38 | 59.51 | -182.81 | 26.19 | 28.76 | 51.18 |
Other Investing Activities | -0.05 | 0.12 | 0.43 | 1.42 | -1.01 | 0.33 |
Investing Cash Flow | 41.8 | 58.93 | -185.43 | 27.31 | 27.14 | 49.18 |
Long-Term Debt Repaid | - | -5.05 | -5.25 | -4.42 | -4.42 | -4.54 |
Net Debt Issued (Repaid) | -4.91 | -5.05 | -5.25 | -4.42 | -4.42 | -4.54 |
Issuance of Common Stock | - | - | 230.63 | 1.32 | - | - |
Other Financing Activities | 0.03 | 0.03 | - | - | 0.01 | -6.8 |
Financing Cash Flow | -4.88 | -5.02 | 225.38 | -3.1 | -4.42 | -11.35 |
Net Cash Flow | -9.99 | 6.85 | -11.9 | -17.39 | -11.47 | -1.13 |
Free Cash Flow | -47.11 | -47.44 | -54.57 | -41.89 | -34.81 | -41.3 |
Free Cash Flow Margin | -156.80% | -155.85% | -102.76% | -64.20% | -56.48% | -48.14% |
Free Cash Flow Per Share | -0.74 | -0.75 | -0.95 | -0.79 | -0.65 | -0.78 |
Cash Interest Paid | 0.09 | 0.09 | 0.18 | 0.12 | 0.12 | 0.14 |
Cash Income Tax Paid | - | - | 0.01 | - | - | - |
Levered Free Cash Flow | -31.15 | -30.86 | -40.17 | -29.01 | -20.2 | -33.04 |
Unlevered Free Cash Flow | -31.08 | -30.81 | -40.06 | -28.94 | -20.13 | -32.95 |
Change in Working Capital | 5.17 | 8.17 | -20.31 | -16.76 | 1.76 | -30.88 |